This trial uses two existing cancer drugs to see if jointly they increase the survival rate.
Given the ugly side effects, and the liklihood that a marginal but improved outcome is found - I would call this a complimentary treatment to cvac, and possibly subordinate.
The main competition I see (and again it will probably be complimentary) is NV-128 by Novogen but hasn't begun human trials yet.
One of the main pluses to cvac is doesn't have the nasty side effects of chemo and the drugs in the trial above.
- Forums
- ASX - By Stock
- competition
This trial uses two existing cancer drugs to see if jointly they...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
Add IMM (ASX) to my watchlist
|
|||||
Last
33.3¢ |
Change
-0.003(0.75%) |
Mkt cap ! $486.6M |
Open | High | Low | Value | Volume |
33.5¢ | 33.5¢ | 33.0¢ | $27.17K | 81.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 599765 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 74423 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 599765 | 0.330 |
15 | 284251 | 0.325 |
19 | 546357 | 0.320 |
10 | 192053 | 0.315 |
9 | 77210 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.335 | 74423 | 10 |
0.340 | 105230 | 8 |
0.345 | 112097 | 9 |
0.350 | 56902 | 8 |
0.355 | 185346 | 8 |
Last trade - 11.15am 02/08/2024 (20 minute delay) ? |
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
IMM (ASX) Chart |